An aerosol delivery device includes a chamber for receiving an article including an aerosolizable material for delivery by the aerosol delivery device, a transmitter, a receiver spaced apart from the transmitter, and a processor. The processor is configured to: cause the transmitter to transmit a first signal to the receiver at least partially through an article in the chamber in use, so that the receiver receives a second signal, wherein the second signal is the first signal altered by interaction with a signal altering component of the article, and determine article data from the second signal. An article includes an aerosolizable material; and a signal altering component. The signal altering component is configured to alter a first signal transmitted at least partially through the article into a second signal indicative of article data.

An aerosol delivery device includes a chamber for receiving an article including an aerosolizable material for delivery by the aerosol delivery device, a transmitter, a receiver spaced apart from the transmitter, and a processor. The processor is configured to: cause the transmitter to transmit a first signal to the receiver at least partially through an article in the chamber in use, so that the receiver receives a second signal, wherein the second signal is the first signal altered by interaction with a signal altering component of the article, and determine article data from the second signal. An article includes an aerosolizable material; and a signal altering component. The signal altering component is configured to alter a first signal transmitted at least partially through the article into a second signal indicative of article data.

A system for mental health clinical application includes a virtual reality (VR) headset, a physiological sensor device and a computer device. The computer device is used to perform an illness test on a user by establishing a virtual 3D environment via the VR headset according to test data provided by the computer device. The computer device receives, from the physiological sensor device, a physiological signal of the user in response to the illness test to analyze an illness condition of the user.

Aspects include a method, system and computer program product for alleviating an episode of a movement disorder condition for a patient. The method comprises deploying an unmanned aerial vehicle (UAV) to a location of a patient based on an occurrence of an episode of a movement disorder condition. A first gross sensory change stimulus is selected with a processor. The first gross sensory change stimulus is projected from the UAV. An attempt to alleviate the episode of the movement disorder condition is performed based at least in part on the projecting of the first gross sensory change stimulus from the UAV. The alleviating of the episode of the movement disorder condition is detected based on the gross sensory change stimulus from the UAV.

Aspects include a method, system and computer program product for alleviating an episode of a movement disorder condition for a patient. The method comprises deploying an unmanned aerial vehicle (UAV) to a location of a patient based on an occurrence of an episode of a movement disorder condition. A first gross sensory change stimulus is selected with a processor. The first gross sensory change stimulus is projected from the UAV. An attempt to alleviate the episode of the movement disorder condition is performed based at least in part on the projecting of the first gross sensory change stimulus from the UAV. The alleviating of the episode of the movement disorder condition is detected based on the gross sensory change stimulus from the UAV.

Embodiments of an adaptor for delivering diffused aromatic agents to a user of a CPAP machine is disclosed in this document. The adaptor may include a connector body, a diffuser pad disposed within the connector body, and at least one coupling mechanism on the connector body coupling the connector body within the air supply and positioning the diffuser pad within the airflow of a CPAP machine. The adaptor may be configured to couple directly to a CPAP mask. Similarly, the adaptor may be configured to be placed in the airflow between the CPAP air generator and the mask. The adaptor may be configured such that no modification of the existing CPAP hose, machine, or mask is required.

Embodiments of an adaptor for delivering diffused aromatic agents to a user of a CPAP machine is disclosed in this document. The adaptor may include a connector body, a diffuser pad disposed within the connector body, and at least one coupling mechanism on the connector body coupling the connector body within the air supply and positioning the diffuser pad within the airflow of a CPAP machine. The adaptor may be configured to couple directly to a CPAP mask. Similarly, the adaptor may be configured to be placed in the airflow between the CPAP air generator and the mask. The adaptor may be configured such that no modification of the existing CPAP hose, machine, or mask is required.

Lighting systems, methods, and devices for protecting human circadian neuroendocrine function during night use are described. Suitable lighting conditions can be provided for a working environment while protecting the circadian neuroendocrine systems of those occupying the illuminated workplace during the night. Lighting systems, methods, and devices can provide substantive attenuation of the pathologic circadian disruption in night workers. Lighting systems, methods, and devices can attenuate the specific bands of light implicated in circadian disruption. LED lighting systems, methods, and devices can provide increased intensity at a different portion of the spectrum than conventional LEDs, providing a useable white light even when unfavorable portions of the wavelength are attenuated by a notch filter. LED lighting systems, methods, and devices can switch between a daytime configuration and a night time configuration, wherein the daytime configuration provides unfiltered light and the night time configuration provides filtered light.

Lighting systems, methods, and devices for protecting human circadian neuroendocrine function during night use are described. Suitable lighting conditions can be provided for a working environment while protecting the circadian neuroendocrine systems of those occupying the illuminated workplace during the night. Lighting systems, methods, and devices can provide substantive attenuation of the pathologic circadian disruption in night workers. Lighting systems, methods, and devices can attenuate the specific bands of light implicated in circadian disruption. LED lighting systems, methods, and devices can provide increased intensity at a different portion of the spectrum than conventional LEDs, providing a useable white light even when unfavorable portions of the wavelength are attenuated by a notch filter. LED lighting systems, methods, and devices can switch between a daytime configuration and a night time configuration, wherein the daytime configuration provides unfiltered light and the night time configuration provides filtered light.

There is described a method and system for measuring a level of anxiety. Measured data comprising EEG data collected from a parietal (P) EEG electrode is received. A group 8 indicator based on a power, P-power (dt), associated with a delta-theta frequency band, dt, within a delta-theta frequency range is extracted. Based on said group 8 indicator, a level of anxiety, LoA, is determined which is a value indicative of the level of anxiety of the subject.